Catalyst Wire Dossier Catalyst Wire Dossier

VAX125

· VaxInnate Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VAX125, covering 2011-07-14 to 2014-09-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Safety and Immunogenicity Study in Healthy Adults of VAX125, a Recombinant HA-flagellin Influenza Vaccine [Phase 1]

See pricing